UA-118257413-1 UA-124410294-1 hih | news | 7.10

Jul

2010

Cancer detection co BioView reports Japan sale

The company believes that the system could lead to more purchases by commercial laboratories in Japan.
 July 26, 2010 11:39, Globes' correspondent


BioView Ltd. (TASE:BIOV) has sold a scanning system to a laboratory in Tokyo, the company's second sale in Japan. This is the first sale to a commercial laboratory. The company did not disclose the value of the deal or the name of the customer.
The new sale is to one of Japan's top laboratories, which undertakes 200 million tests for both domestic and foreign customers.

BioView develops an automated cell diagnostic system for use in cytology, hematology and pathology laboratories. The company’s flagship system is the Duet automated scanning imaging workstation, the Solo offline workstation with proprietary software, and various preparation kits.

BioView believes that the system could lead to more purchases by commercial laboratories in Japan.

BioView's share price rose 4.8% in morning trading to NIS 1.47, giving a market cap of NIS 18 million